Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

The Biden administration was a disaster for Texas. Its failures to address inflation, illegal immigration, and homelessness ...

Eli Lilly stock rises more than 11% as weight loss pill orforglipron shows promising trial results, raising hopes for a ...

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

Rival companies trying to develop oral weight-loss candidates include Novo Nordisk, which has an oral formulation of ...

Six years after the FDA approved Zolgensma, a Novartis gene therapy for spinal muscular atrophy for children under age 2, investigators ... approved, Roche won approval for a pill.

The new results are from a phase 1 trial of a once-daily pill ... that Roche said were "consistent with the safety profile of the incretin drug class," and will now progress to phase 2.